France· FR:60470990
FRAXIPARINE 5 700 U.I. Axa/0,6 ml, solution injectable (S.C.) en seringue pré-remplie
A nadroparin product containing nadroparine calcique, registered in France by VIATRIS SANTE, on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Nadroparin is registered in 8 of 19 countries.
Countries holding a registration under ATC B01AB06 (nadroparin), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 6 of them publish a price we can compare per daily dose
Nadroparin · ATC B01AB06
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- NADROPARINE CALCIQUE
- Manufacturer
- VIATRIS SANTE
- Country
- France (FR)
- ATC code
- B01AB06
- ATC class
- Nadroparin
- Defined daily dose
- 2.85 TSD, E
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 3
3 priced- cip1334009327828572 seringue(s) préremplie(s) en verre de 0,6 ml avec système de sécurité : manchon plastique transparentEUR 12.39
- cip13340093278316810 seringue(s) préremplie(s) en verre de 0,6 ml avec système de sécurité : manchon plastique transparentEUR 61.25
- cip1334009334876146 seringue(s) préremplie(s) en verre de 0,6 ml avec système de sécurité : manchon plastique transparentEUR 36.95
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nadroparin in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c189c3eb-bf3b-42bb-af83-313a04498870 GET /v1/drugs/c189c3eb-bf3b-42bb-af83-313a04498870?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60470990",
"date_amm": "1985-03-04",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "NADROPARINE CALCIQUE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "sous-cutanée;voie extracorporelle autre",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about nadroparin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.